Logo
x

Search

Subscribe Now

Emergent BioSolutions

Emergent BioSolutions Entered into a Definitive Agreement with Chimerix to Acquire Tembexa (brincidofovir) Rights for Smallpox

Emergent BioSolutions Entered into a Definitive Agreement with Chimerix to Acquire Tembexa (brincidofovir) Rights for Smallpox

  • May 16, 2022
Insights+: COVID-19 Healthcare News Monthly Updates - July 2020

Insights+: COVID-19 Healthcare News Monthly Updates - July 2020

  • July 31, 2020
AstraZeneca Signs an Agreement with Emergent BioSolutions to Expand Manufacturing of AZD1222 for COVID-19

AstraZeneca Signs an Agreement with Emergent BioSolutions to Expand Manufacturing of AZD1222 for COVID-19

  • July 28, 2020
Top COVID-19 Deals (Part II): Biopharma Vaccine Development

Top COVID-19 Deals (Part II): Biopharma Vaccine Development

  • May 1, 2020
Insights+: COVID-19 Healthcare News Monthly Updates - August 2020

Insights+: COVID-19 Healthcare News Monthly Updates - August 2020

  • April 9, 2020
Emergent BioSolutions Announces Completion of Acquisition of PaxVax for ~$270M

Emergent BioSolutions Announces Completion of Acquisition of PaxVax for ~$270M

  • October 5, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.